GenFleet Therapeutics (Shanghai) Inc. (HKG:2595)
Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
36.50
-0.48 (-1.30%)
At close: Apr 2, 2026

HKG:2595 Income Statement

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023
Period Ending
Dec '25 Dec '24 Dec '23
130.27104.773.73
Revenue Growth (YoY)
24.42%42.00%-
Cost of Revenue
46.6120.10.68
Gross Profit
83.6684.6173.05
Selling, General & Admin
81.3858.0849.95
Research & Development
282.26303.32308.94
Operating Expenses
363.64361.41358.88
Operating Income
-279.98-276.8-285.83
Interest Expense
-6.39-6.12-1.49
Interest & Investment Income
-17.2310.77
Currency Exchange Gain (Loss)
-3.543.82
Other Non Operating Income (Expenses)
10.85-4.9721.75
EBT Excluding Unusual Items
-275.53-267.12-250.98
Gain (Loss) on Sale of Investments
-0.43.59
Gain (Loss) on Sale of Assets
--0.01-0.14
Other Unusual Items
-1,519-410.91-260.79
Pretax Income
-1,794-677.64-508.32
Income Tax Expense
0.15--
Net Income
-1,795-677.64-508.32
Net Income to Common
-1,795-677.64-508.32
Shares Outstanding (Basic)
2962622
Shares Outstanding (Diluted)
2962622
Shares Change (YoY)
1043.91%17.40%-
EPS (Basic)
-6.07-26.20-23.08
EPS (Diluted)
-6.07-26.20-23.08
Free Cash Flow
--206.64-202.65
Free Cash Flow Per Share
--7.99-9.20
Gross Margin
64.22%80.81%99.07%
Operating Margin
-214.93%-264.36%-387.66%
Profit Margin
-1377.58%-647.20%-689.40%
Free Cash Flow Margin
--197.35%-274.85%
EBITDA
-271.49-268.3-274.33
EBITDA Margin
-208.41%-256.25%-
D&A For EBITDA
8.58.511.5
EBIT
-279.98-276.8-285.83
EBIT Margin
-214.93%-264.36%-
Source: S&P Global Market Intelligence. Standard template. Financial Sources.